Quotient biodiagnostics, INC.:1217134 [14-005783]
Ended Awarded
- Contract number
- HHSN269201400252U
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Office of the Chief Operating Officer
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,074
Award facts
- Contract value 100% obligated
- $9,074.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, awarded by the Department of Veterans Affairs (VA), is a Blanket Purchase Agreement (BPA) under the VA's VISN 10 network, with a ceiling value of $109,420.35 and a period of performance through September 2029. This BPA allows VA medical facilities within VISN 10 to efficiently procure red blood cell reagents and other critical blood banking supplies from Alba Bioscience under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. The contract does not have a set-aside designation, reflecting the specialized nature of Alba Bioscience's medical offerings. This award is part of Alba Bioscience's broader portfolio of federal contracts, including another BPA with the VA's VISN 1 network valued at $30,000 and extending through September 2028, which enables the streamlined procurement of blood bank reagents and related products.
Quick answers
Who was awarded contract HHSN269201400252U?
HHSN269201400252U was awarded to Alba Bioscience, Inc. by Office of the Chief Operating Officer (National Institutes of Health) on February 20, 2014.
How much is contract HHSN269201400252U worth?
The government has obligated $9,074 on HHSN269201400252U.
Is contract HHSN269201400252U an order under another contract?
Yes. HHSN269201400252U is a delivery order under V797P2050D, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HHSN269201400252U competed?
The extent of competition for HHSN269201400252U was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award